CapsoVision (CV) EBITDA (2024 - 2025)
CapsoVision's (CV) quarterly EBITDA came in at -$7.5 million in Q4 2025, down 61.07% year-on-year from -$19.2 million in Q4 2024, and up 6.92% quarter-over-quarter from -$8.0 million in Q3 2025.
CapsoVision (CV) EBITDA (2024 - 2025) Analysis & Trends
CapsoVision has disclosed EBITDA across 2 years of filings, most recently posting -$7.5 million for Q4 2025.
- EBITDA for Q4 2025 came in at -$7.5 million, down 61.07% year-over-year; the trailing twelve-month figure through Dec 2025 was -$24.8 million (changed N/A YoY), and the FY2025 annual result was -$25.5 million, down 28.11% from the prior year.
- EBITDA came in at -$7.5 million for Q4 2025 at CapsoVision, up from -$8.0 million in the prior quarter.
- In the past five years, EBITDA ranged from a high of -$4.6 million in Q4 2024 to a low of -$8.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 1.46 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 477.60 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 515.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 663.81 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 255.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 316.80 Mn |
| 10 | CapsoVision | 176.55 Mn | 166.44 Mn | 1.95 Mn | -7.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -7.46 Mn |
| Sep 30, 2025 | -8.02 Mn |
| Jun 30, 2025 | -4.65 Mn |
| Dec 31, 2024 | -4.63 Mn |
| Sep 30, 2024 | -5.80 Mn |
| Jun 30, 2024 | -5.27 Mn |